CLB
Core Laboratories NV
11.30$
-1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.8% | -39.8% | -5.8% | -10.0% | -19.9% | -35.4% | -36.8% | -31.8% | -0.7% | +127.5% | -34.3% | |
| – | +2.9% | -2.1% | -7.2% | -7.4% | -2.1% | -7.7% | -11.3% | -7.3% | -8.0% | -5.3% | -2.0% | |
| – | +4.0% | +3.8% | +3.9% | +49.0% | -38.9% | -64.6% | +158.2% | -59.4% | +80.1% | -73.1% | +90.1% | |
| – | +22.4% | -81.7% | +361.0% | +39.2% | -180.4% | – | – | +29.2% | – | – | – | |
| – | – | -25.1% | -126.7% | – | – | – | -132.8% | – | – | – | -284.4% | |
| – | -35.2% | -51.8% | +60.4% | +15.8% | +2.4% | -46.7% | +14.0% | -24.5% | +3.6% | +23.1% | +13.1% | |
| – | -5.7% | -62.9% | +39.6% | +243.6% | -92.0% | – | -230.2% | -62.3% | +72.5% | -3.9% | -65.1% | |
| – | +5.8% | +1.0% | +2.1% | +0.1% | +0.3% | -87.2% | -85.3% | +1.0% | +0.8% | +0.4% | -0.4% | |
| – | -39.6% | -95.5% | +136.1% | -55.9% | -55.7% | -15.3% | +195.5% | -52.7% | -43.6% | +141.0% | +134.2% | |
| – | -14.1% | -388.3% | – | +522.4% | -75.9% | -416.9% | +49.4% | -75.8% | -47.7% | +322.2% | -60.5% | |
| – | -31.5% | -30.7% | -16.7% | -59.2% | +102.2% | -26.6% | -64.4% | +4.1% | -21.1% | +149.2% | -32.0% | |
| – | – | – | – | – | – | – | +43.6% | -158.4% | – | – | -12.2% | |
| – | -26.8% | -38.3% | -12.2% | -14.6% | -25.3% | -31.6% | -49.9% | -36.0% | -3.6% | +205.1% | -48.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.